Search

Search Results

• 

  Association between the response to B cell depletion therapy and the allele*2 of the HS1,2A enhancer in seropositive rheumatoid arthritis patients

  S. Canestri, M.C. Totaro, E. Serone, B. Tolusso, D. Frezza, E. Gremese, G. Ferraccioli

  368-373

  20-12-2012

  Published: 20 December 2012

  1964

  PDF: 754
• 

  The signal transducer and activator of transcription factors lodge in immunopathogenesis of rheumatoid arthritis

  F. Zare, M. Dehghan-Manshadi, A. Mirshafiey

  127-137

  23-05-2016

  Published: 23 May 2016

  2394

  PDF: 1060
• 

  Evaluation of Th9 lymphocytes in peripheral blood of rheumatoid arthritis patients and correlation with anti-tumor necrosis factor therapy: results from an in vitro pivotal study

  R. Talotta, A. Berzi, F. Atzeni, D. Dell'Acqua, P. Sarzi Puttini, D. Trabattoni

  83-89

  09-09-2016

  Published: 9 September 2016

  1698

  PDF: 868

  IL RUOLO DEI LINFOCITI TH9 NELL'ARTRITE REUMATOIDE E NELLA RISPOSTA AL TRATTAMENTO CON INFLIXIMAB.: 0
• 

  Low body mass index in long standing rheumatoid arthritis: relation to RA disease activity and functional indices

  S.M. Gamal, A.K. Alkemary, M.A. Abdo, A.H.M. El Dakrony

  72-77

  06-07-2018

  Published: 6 July 2018

  1384

  PDF: 667
• 

  Fas/FasL promoter gene polymorphism in patients with rheumatoid arthritis

  Ş. Kobak, A. Berdeli

  374-379

  20-12-2012

  Published: 20 December 2012

  2088

  PDF: 1081
• 

  Influence of TNF-α inhibition on oxidative stress of rheumatoid arthritis patients

  F. Cacciapaglia, M.G. Anelli, D. Rizzo, E. Morelli, C. Scioscia, D. Mazzotta, F. Iannone, G. Lapadula

  97-102

  09-02-2016

  Published: 9 February 2016

  1931

  PDF: 1190

• Biologics targeted at TNF: design, production and challenges

  B. Gatto

  94-103

  Published:

  1753

  PDF: 2486
• 

  Possible relationship between certolizumab pegol and arrhythmias: report of two cases

  R. Talotta, F. Atzeni, A. Batticciotto, D. Ventura, P. Sarzi-Puttini

  104-108

  09-09-2016

  Published: 9 September 2016

  1432

  PDF: 913
• 

  B cell autoimmunity and bone damage in rheumatoid arthritis

  S. Bugatti, L. Bogliolo, C. Montecucco, A. Manzo

  117-125

  16-12-2016

  Published: 16 December 2016

  2932

  PDF: 1856
• 

  Anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus patients with articular involvement: a predictive marker for erosive disease?

  M. Taraborelli, F. Inverardi, M. Fredi, A. Ceribelli, I. Cavazzana, A. Tincani, F. Franceschini

  321-325

  11-12-2012

  Published: 11 December 2012

  1577

  PDF: 1172
• 

  Osteoporosis and rheumatic diseases

  N. Maruotti, A. Corrado, F.P. Cantatore

  125-135

  28-06-2014

  Published: 28 June 2014

  7440

  PDF: 3190
• 

  Safety of rituximab in the routine treatment of rheumatoid arthritis in Italy in patients refractory to anti-TNFa drugs: results from the observational retrospective-prospective RUBINO study

  L. Bazzichi, D. Biasi, E. Tinazzi, M. Muratore, R. Pellerito, R. Russo, M. Corsaro Santi, P. De Sandre, O. Epis, M. Granata, B. Kroegler, C. Meschini, F. Versace, C. Astolfi

  224-232

  06-11-2014

  Published: 6 November 2014

  2122

  PDF: 1506

• Central nervous system involvement in patients with HCV-related cryoglobulinemia: review and a case report

  D. Filippini, F. Colombo, S. Jann, R. Corneo, B. Canesi

  150-155

  Published:

  1329

  PDF: 1693
• 

  Primary Sjögren syndrome: report of a 10 years old girl with local edema and positivity of anti SS-A and anti SS-B autoantibodies

  E. Shahi, C. Donati, M. Gattinara, I. Pontikaki, V. Gerloni

  97-100

  Published:

  1265

  PDF: 815
• 

  Acquired hemophilia A treated with rituximab in a 62-year-old female with rheumatoid arthritis: a case-based review

  D. Mohamadzadeh, S. Assar, F. Farsad

  19-12-2023

  Published: 19 December 2023

  904

  PDF: 251

• Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNFα agents failed are associated with response to rituximab in rheumatoid arthritis

  L. Quartuccio, S. Salvin, M. Saracco, S. Lombardi, M. Fabris, E. Mansutti, M. Maset, S. Pellerito, S. De Vita

  182-186

  Published:

  961

  PDF: 664

• Systemic lupus erythematosus induced by anti-tumor necrosis factor α therapy in inflammatory rheumatic diseases: a case series

  D. Oliveira, A. Martins, F. Martins, C. Gomes, S. Pimenta, C. Vaz, L. Costa, M. Bernardes

  24-09-2024

  Published: 24 September 2024

  392

  PDF: 100

• Recurrent acute idiopathic pericarditis: rheumatologic therapy, autoantibodies and long term outcome

  G. Brambilla, A. Brucato, Y. Adler, M. Bosetti, P. Coppini, A. Caforio, D. Spodick, B. Canesi

  25-31

  Published:

  1180

  PDF: 1069

• The impact of nicotine smoking on spondyloarthritis and rheumatoid arthritis

  G. El Hasbani, J. E Nassar, A.M. Elsayed Ali, I. Uthman, A. Jawad

  24-06-2024

  Published: 24 June 2024

  2661

  PDF: 1058
• 

  Classification and clinical assessment

  A. Marchesoni, F. Cantini

  79-87

  05-06-2012

  Published: 5 June 2012

  1137

  PDF: 1943

• Outcome predictors in rheumatoid arthritis

  C. Montecucco

  21-27

  Published:

  855

  PDF: 863
• 

  Adherence to treatment and associated factors in rheumatoid arthritis patients: a cross-sectional study from Iran

  D. Mohamadzadeh, S. Assar, M. Pournazari, P. Soufivand, M.S. Soleymani

  08-05-2023

  Published: 8 May 2023

  1214

  PDF: 527
• 

  A case of false positive Troponin I in a patient affected by cryoglobulinemic vasculitis

  M. Bellan, M. Pirisi, G. Bellomo, P.P. Sainaghi

  40-42

  22-05-2017

  Published: 22 May 2017

  1190

  PDF: 696
• 

  Cardiovascular involvement in psoriatic arthritis

  F. Atzeni, M. Turiel, L. Boccassini, S. Sitia, L. Tomasoni, M. Battellino, A. Marchesoni, V. De Gennaro Colonna, P. Sarzi-Puttini

  148-154

  09-11-2011

  Published: 9 November 2011

  1701

  PDF: 916
• 

  Novel autoantibodies in rheumatoid arthritis

  A.F. Bonifacio, A. Alunno, G.M.C. La Paglia, E. Valentini, M.C. Leone, E. Bartoloni, Roberto Gerli

  1-12

  01-04-2019

  Published: 1 April 2019

  2859

  PDF: 1650
• 

  Subcalcaneal bursitis as the initial manifestation of rheumatoid arthritis: ultrasonographic observation of two cases

  T. Suzuki, H. Shirai

  230-234

  28-01-2020

  Published: 28 January 2020

  1299

  PDF: 929

• TNFα blockers and infectious risk in rheumatoid arthritis

  B. Raffeiner, C. Botsios, F. Ometto, L. Bernardi, A. Montante, P. Sfriso, S. Todesco, L. Punzi

  165-173

  Published:

  1527

  PDF: 2050

• Use of antikeratin antibodies to distinguish between rheumatoid arthritis and polyarthritis associated with hepatitis C infection

  A. Kessel, I. Rosner, E. Zuckerman, T.D. Golan, E. Toubi

  156-157

  Published:

  554

  PDF: 473

• Atherosclerosis and rheumatoid arthritis: relationships between intima-media thickness of the common carotid arteries and disease activity and disabilty

  G. Cuomo, P. Di Micco, A. Niglio, G. La Montagna, G. Valentini

  242-246

  Published:

  1446

  PDF: 1241

• Atherosclerosis in rheumatoid arthtritis: the role of high-resolution B mode ultrasound in the measurement of the arterial intima-media thickness

  M. Carotti, F. Salaffi, M. Mangiacotti, A. Cerioni, G.M. Giuseppetti, W. Grassi

  38-49

  Published:

  2025

  PDF: 1028

• Incidence and management of infusion reactions to infliximab in 186 italian patient’s with rheumatoid arthritis: the Padua experience

  C. Botsios, P. Ostuni, S. Todesco

  44-51

  Published:

  1111

  PDF: 1708
• 

  Disseminated cutaneous herpes simplex infection after COVID-19 vaccination in a rheumatoid arthritis patient: a case report and review

  D. Mohamadzadeh, S. Assar, M. Pournazari, P. Soufivand, S. Danaei

  13-09-2022

  Published: 13 September 2022

  1480

  PDF: 790

• Case report: rheumatoid arthritis and large granular lymphocytes syndrome

  F. Ingegnoli, M. Arreghini, B. Panni, R. Capra, F. Galbiati, P. Bonara, A. Marchesoni

  357-360

  Published:

  1026

  PDF: 2081

• The subclinical involvement of the lung in rheumatoid arthritis: evaluation by high-resolution computed tomography

  M. Carotti, F. Salaffi, P. Manganelli, L. Salvolini, E. Bichi Secchi, S. De Berardinis

  280-288

  Published:

  1088

  PDF: 1511

• Association between Serum Amiloid A (SAA) in salivary glands and high levels of circulating β2-microglobulin in patients with Sjögren syndrome

  M. Benucci, F. Li Gobbi, A. Del Rosso, G. Gambacorta, A. Mannoni

  98-101

  Published:

  896

  PDF: 946

• BAFF/APRIL pathway in Sjögren syndrome and systemic lupus erythematosus: relationship with chronic inflammation and disease activity

  M. Vadacca, D. Margiotta, D. Sambataro, F. Buzzulini, M. Lo Vullo, A. Rigon, A. Afeltra

  259-265

  Published:

  1792

  PDF: 1978

• Current therapeutic strategies for HCV-associated cryoglobulinemia

  F. Iannuzzella, G. Garini

  163-173

  Published:

  987

  PDF: 1957

• Comorbidities in rheumatoid arthritis: analysis of hospital discharge records

  M. Parodi, L. Bensi, T. Maio, G.S. Mela, M.A. Cimmino

  154-160

  11-04-2005

  Published: 11 April 2005

  1968

  PDF: 1347

• Prevalence of anti-CCP antibodies in systemic sclerosis

  M. Marrone, A. Chialà, M. Tampoia, F. Iannone, L. Raho, M. Covelli, V. Grattagliano, N. Pansini, G. Lapadula

  20-24

  Published:

  1058

  PDF: 804

• Stress response system and personality in rheumatoid arthritis patients

  C. Prete, F. Briano, C. Pizzorni, A. Sulli, M. Marcenaro, M. Cutolo

  204-209

  Published:

  1311

  PDF: 859

• Blocking TNF in vitro with infliximab determines the inhibition of expansion and interferon gamma production of Vγ9/Vδ2 T lymphocytes from patients with active rheumatoid arthritis. A role in the susceptibility to tuberculosis?

  A.R. Giardina, A. Accardo-Palumbo, F. Ciccia, A. Ferrante, A. Principato, R. Impastato, G. Triolo

  21-26

  Published:

  1348

  PDF: 1063

• Early rheumatoid arthritis

  F. Atzeni, P. Sarzi-Puttini

  100-117

  Published:

  1389

  PDF: 2039

• Efficacy and safety of anti-TNF agents in the Lombardy rheumatoid arthritis network (LORHEN)

  P. Sarzi- Puttini, M. Antivalle, A. Marchesoni, E.G. Favalli, R. Gorla, M. Filippini, R. Caporali, F. Bobbio-Pallavicini, C. Montecucco, F. Atzeni

  290-295

  Published:

  1987

  PDF: 1035

• Safety of rituximab in rheumatoid arthritis

  M. Covelli, P. Sarzi-Puttini, F. Atzeni, P. Macchioni

  101-106

  Published:

  1586

  PDF: 960

• Accuracy and standardization of diagnostic methods for the detection of antibodies to citrullinated peptides

  N. Bizzaro, M. Tampoia

  222-228

  Published:

  1030

  PDF: 828

• Switching between TNFα antagonists in rheumatoid arthritis: personal experience and review of the literature

  R. Scrivo, F. Conti, F.R. Spinelli, S. Truglia, L. Magrini, M. Di Franco, F. Ceccarelli, G. Valesini

  107-117

  Published:

  1815

  PDF: 1067

• Usefulness of anti-cyclic citrullinate peptide antibody determination in synovial fluid analysis of patients with rheumatoid arthritis

  A. Spadaro, V. Riccieri, C. Alessandri, R. Scrivo, G. Valesini

  116-120

  Published:

  1163

  PDF: 1120

• “THE LEEDS IDEA”: AN HISTORICAL ACCOUNT OF THE SPONDARTHRITIS CONCEPT

  J.M.H. Moll

  13-18

  Published:

  751

  PDF: 716
• 

  Frequency of ANA/DFS70 autoantibodies in Colombian patients with undifferentiated connective tissue disease

  D. Rincón-Riaño, D.G. Fernández-Ávila, D. Acero-Molina, J.M. Bello Gualtero , C. Romero-Sánchez

  13-09-2022

  Published: 13 September 2022

  1268

  PDF: 699

• Fibronectin gene polymorphisms and clinical manifestations of mixed cryoglobulinemic syndrome: increased risk of lymphoma associated to MspI DD and HaeIII AA genotypes

  M. Fabris, L. Quartuccio, V. De Re, G. Pozzato, C. Mazzaro, A. Tavoni, C. Ferri, S. Salvin, A. Lerussi, C. Fabro, S. Bombardieri, S. De Vita

  28-34

  Published:

  1400

  PDF: 604